Anna Weiss

Institute of Medical Microbiology and Hygiene

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy”.

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy

New England Journal of Medicine(2025)10.1056/nejmoa2414859

N/A

1.2DataRank · unranked

93 citations

Hanna Bandos, Julia White, Thomas B. Julian, Atif J. Khan, Simona F. Shaitelman +23 more

Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer

Future Oncology(2021)10.2217/fon-2021-0753

N/A

0.901DataRank · unranked

30 citations

Karla V. Ballman, Linda McCall, Anuhya Kommalapati, Tyler Zemla, Anna Weiss +12 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

JAMA Oncology(2024)10.1001/jamaoncol.2023.6038

N/A

0.819DataRank · unranked

21 citations

Vera J. Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag, A. Marilyn Leitch +25 more

Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts

Cancer(2023)10.1002/cncr.34750

N/A

0.416DataRank · unranked

15 citations

Olga Martínez‐Sáez, Adrienne G. Waks, Alison Laws, Monica McGrath, Paolo Tarantino +11 more

Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study

The Lancet Oncology(2025)10.1016/s1470-2045(25)00598-4

N/A

0.416DataRank · unranked

15 citations

Michael Alvarado, Sara Myers, Mary M Mrdutt, Susie X. Sun, Varadan Sevilimedu +95 more

Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12001

N/A

0.360DataRank · unranked

10 citations

Karla V. Ballman, Linda McCall, Pamela J. Goodwin, Anna Weiss, Linda M. Delahanty +15 more

Germline genetic mutations in a multi-center cohort of 248 phyllodes tumors

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07488-3

N/A

0.269DataRank · unranked

5 citations

Samantha Thomas, Tina J. Hieken, Kristalyn K. Gallagher, Philip M. Spanheimer, Heather B. Neuman +11 more

Feasibility of antimicrobial photodynamic therapy for treatment of breast abscesses: Retrospective Monte Carlo simulation study

Photochemistry and Photobiology(2025)10.1111/php.14085

N/A

0DataRank · unranked

1 citations

Lam Nguyen, Sophia Palumbo, Anna Weiss, Nebojsa Duric, Timothy M. Baran

Germline genetic mutations in a multi-center cohort of 248 phyllodes tumors

UNC Libraries(2025)10.17615/3d4p-cb05

N/A

0DataRank · unranked

0 citations

James W. Jakub, Barry Tong, Carolyn S. Menendez, Amanda L. Nash, E. Shelley Hwang +11 more

A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.36_suppl.360922

N/A

0DataRank · unranked

16 citations

Karla V. Ballman, Eric P. Winer, Thomas H. Openshaw, Olwen Hahn, Frederick Briccetti +10 more

Systemic Therapy Advances for HER2-Positive and Triple Negative Breast Cancer: What the Surgeon Needs to Know

Clinical Breast Cancer(2024)10.1016/j.clbc.2024.03.004

N/A

0DataRank · unranked

9 citations

Anna Weiss, Stephanie Downs‐Canner

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

UNC Libraries(2024)10.17615/41px-cd59

N/A

0DataRank · unranked

1 citations

Travis Dockter, Amy Tiersten, Matthew J. Ellis, Kelly K. Hunt, Wajeeha Razaq +25 more

Commentary and Updates on the Management of Male Breast Cancer

Annals of Surgical Oncology(2025)10.1245/s10434-024-16756-x

N/A

0DataRank · unranked

5 citations

Austin D. Williams, Anna Weiss, Collaborators from the Society of Surgical Oncology Breast Disease Site Work Group, Oluwadamilola M. Fayanju, Doreen M. Agnese +7 more

A Clinical Decision Support Tool to Predict Contralateral Breast Cancer Risk for Women with Primary Breast Cancer

Medical Research Archives(2025)10.18103/mra.v13i7.6814

N/A

0DataRank · unranked

1 citations

Theodore Huang, Jill E. Stopfer, Judy Garber, Anna Weiss, Danielle Braun

Exploring racial differences in second-harmonic-generation–based prognostic indicators of metastasis in breast and colon cancer

Biophotonics discovery.(2025)10.1117/1.bios.2.2.022703

N/A

0DataRank · unranked

2 citations

Danielle E. Desa, Edward B. Brown, Showmick Paul, Gabriel Ramirez, Bradley M. Turner +4 more